This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belshan, M.
Right arrow Articles by Carpenter, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belshan, M.
Right arrow Articles by Carpenter, S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2000, p. 3550-3557, Vol. 20, No. 10
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Binding of Equine Infectious Anemia Virus Rev to an Exon Splicing Enhancer Mediates Alternative Splicing and Nuclear Export of Viral mRNAs

Michael Belshan,1 Gregory S. Park,1 Patricia Bilodeau,2 C. Martin Stoltzfus,2 and Susan Carpenter1,*

Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, Iowa 50011,1 and Department of Microbiology, University of Iowa, Iowa City, Iowa 522422

Received 15 October 1999/Returned for modification 30 November 1999/Accepted 22 February 2000

In addition to facilitating the nuclear export of incompletely spliced viral mRNAs, equine infectious anemia virus (EIAV) Rev regulates alternative splicing of the third exon of the tat/rev mRNA. In the presence of Rev, this exon of the bicistronic RNA is skipped in a fraction of the spliced mRNAs. In this report, the cis-acting requirements for exon 3 usage were correlated with sequences necessary for Rev binding and transport of incompletely spliced RNA. The presence of a purine-rich exon splicing enhancer (ESE) was required for exon 3 recognition, and the addition of Rev inhibited exon 3 splicing. Glutathione-S-transferase (GST)-Rev bound to probes containing the ESE, and mutation of GAA repeats to GCA within the ESE inhibited both exon 3 recognition in RNA splicing experiments and GST-Rev binding in vitro. These results suggest that Rev regulates alternative splicing by binding at or near the ESE to block SR protein-ESE interactions. A 57-nucleotide sequence containing the ESE was sufficient to mediate Rev-dependent nuclear export of incompletely spliced RNAs. Rev export activity was significantly inhibited by mutation of the ESE or by trans-complementation with SF2/ASF. These results indicate that the ESE functions as a Rev-responsive element and demonstrate that EIAV Rev mediates exon 3 exclusion through protein-RNA interactions required for efficient export of incompletely spliced viral RNAs.

* Corresponding author. Mailing address: Dept. of VMPM, Rm. 1136 Vet Med, Iowa State University, Ames, IA 50011. Phone: (515) 294-5158. Fax: (515) 294-8500. E-mail: scarp{at}iastate.edu.

Molecular and Cellular Biology, May 2000, p. 3550-3557, Vol. 20, No. 10
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Mertz, J. A., Chadee, A. B., Byun, H., Russell, R., Dudley, J. P. (2009). Mapping of the Functional Boundaries and Secondary Structure of the Mouse Mammary Tumor Virus Rem-responsive Element. J. Biol. Chem. 284: 25642-25652 [Abstract] [Full Text]  
  • Groom, H. C. T., Anderson, E. C., Lever, A. M. L. (2009). Rev: beyond nuclear export. J. Gen. Virol. 90: 1303-1318 [Abstract] [Full Text]  
  • Bogerd, H. P., Tallmadge, R. L., Oaks, J. L., Carpenter, S., Cullen, B. R. (2008). Equine Infectious Anemia Virus Resists the Antiretroviral Activity of Equine APOBEC3 Proteins through a Packaging-Independent Mechanism. J. Virol. 82: 11889-11901 [Abstract] [Full Text]  
  • Lee, J.-H., Murphy, S. C., Belshan, M., Sparks, W. O., Wannemuehler, Y., Liu, S., Hope, T. J., Dobbs, D., Carpenter, S. (2006). Characterization of Functional Domains of Equine Infectious Anemia Virus Rev Suggests a Bipartite RNA-Binding Domain. J. Virol. 80: 3844-3852 [Abstract] [Full Text]  
  • Baccam, P., Thompson, R. J., Li, Y., Sparks, W. O., Belshan, M., Dorman, K. S., Wannemuehler, Y., Oaks, J. L., Cornette, J. L., Carpenter, S. (2003). Subpopulations of Equine Infectious Anemia Virus Rev Coexist In Vivo and Differ in Phenotype. J. Virol. 77: 12122-12131 [Abstract] [Full Text]  
  • Adams, D. J., van der Weyden, L., Mayeda, A., Stamm, S., Morris, B. J., Rasko, J. E.J. (2001). ZNF265--a novel spliceosomal protein able to induce alternative splicing. JCB 154: 25-32 [Abstract] [Full Text]  
  • Guo, W., Winistorfer, S. C., Stoltzfus, C. M. (2000). Selective Inhibition of Splicing at the Avian Sarcoma Virus src 3' Splice Site by Direct-Repeat Posttranscriptional cis Elements. J. Virol. 74: 8513-8523 [Abstract] [Full Text]  
  • Chung, H.-k., Derse, D. (2001). Binding Sites for Rev and ASF/SF2 Map to a 55-Nucleotide Purine-rich Exonic Element in Equine Infectious Anemia Virus RNA*. J. Biol. Chem. 276: 18960-18967 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»